Skip to main content
Erschienen in: European Radiology 12/2022

18.04.2022 | Paediatric

Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results

verfasst von: Adarsh Ghosh, Ensar Yekeler, Deepa Dalal, Alexandria Holroyd, Lisa States

Erschienen in: European Radiology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the role of apparent diffusion coefficient (ADC) histogram analysis in the identification of MYCN-amplification status in neuroblastomas.

Methods

We retrospectively evaluated imaging records from 62 patients with neuroblastomas (median age: 15 months (interquartile range (IQR): 7–24 months); 38 females) who underwent magnetic resonance imaging at our institution before the initiation of any therapy or biopsy. Fourteen patients had MYCN-amplified (MYCNA) neuroblastoma. Histogram parameters of ADC maps from the entire tumour was obtained from the baseline images and the normalised images. The Mann-Whitney U test was used to compare the absolute and normalised histogram parameters amongst neuroblastomas with and without MYCN-amplification. Receiver operating characteristic (ROC) curves and area under the curves (AUC) were generated for the statistically significant histogram parameters. Cut-offs obtained from the ROC curves were evaluated on an external validation set (n-15, MYCNA-6, F-7, age 24 months (10–60)). A logistic regression model was trained to predict MYCNA by combining statistically significant histogram parameters and was evaluated on the validation set.

Results

MYCN-amplified neuroblastomas had statistically significant higher maximum ADC and lower minimum ADC than non-amplified neuroblastomas. They also demonstrated higher entropy, variance, energy, and lower uniformity than non-amplified neoplasms (p > 0.05). Energy, entropy, and maximum ADC had AUC of 0.85, 0.79, and 0.82, respectively.

Conclusions

Whole tumour ADC histogram analysis of neuroblastomas can differentiate between tumours with and without MYCN-amplification. These parameters can help identify areas for targeted biopsies or can be used to predict subtypes of these high-risk tumours before biopsy results are available.

Key Points

• MYCN-amplification significantly affects treatment decisions in neuroblastomas.
• MYCN-amplified neuroblastomas had significantly different ADC histogram metrics as compared to tumours without amplification.
• ADC histogram metrics can be used to predict MYCN-amplification status based on imaging.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
7.
Zurück zum Zitat Katzenstein HM, Bowman LC, Brodeur GM, et al (1998) Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol 16:2007–2017. https://doi.org/10.1200/JCO.1998.16.6.2007 Katzenstein HM, Bowman LC, Brodeur GM, et al (1998) Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study. J Clin Oncol 16:2007–2017. https://​doi.​org/​10.​1200/​JCO.​1998.​16.​6.​2007
Metadaten
Titel
Whole-tumour apparent diffusion coefficient (ADC) histogram analysis to identify MYCN-amplification in neuroblastomas: preliminary results
verfasst von
Adarsh Ghosh
Ensar Yekeler
Deepa Dalal
Alexandria Holroyd
Lisa States
Publikationsdatum
18.04.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 12/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-022-08750-2

Weitere Artikel der Ausgabe 12/2022

European Radiology 12/2022 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.